Evidence map›Paper›PMID 35262029›Full record

ArticleJournal of clinical virology plus2021

Retrospective epidemiology of the SARS-CoV-2 (and COVID-19) epidemic among 27 Brazilian cities.

Sandra Souza Lima, Maria Alice Freitas Queiroz, Luiz Fernando Almeida Machado, Antonio Carlos Rosário Vallinoto, Marluísa de Oliveira Guimarães Ishak, Ricardo Ishak

Abstract read
In one paragraph

Article in Journal of clinical virology plus, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sandra Souza LimaLaboratório de Virologia, Instituto de Ciências Biológicas, Universidade Federal do Pará.
Maria Alice Freitas QueirozLaboratório de Virologia, Instituto de Ciências Biológicas, Universidade Federal do Pará.
Luiz Fernando Almeida MachadoLaboratório de Virologia, Instituto de Ciências Biológicas, Universidade Federal do Pará.
Antonio Carlos Rosário VallinotoLaboratório de Virologia, Instituto de Ciências Biológicas, Universidade Federal do Pará.
Marluísa de Oliveira Guimarães IshakLaboratório de Virologia, Instituto de Ciências Biológicas, Universidade Federal do Pará.
Ricardo IshakLaboratório de Virologia, Instituto de Ciências Biológicas, Universidade Federal do Pará.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Most of the countries facing the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic are still trying to understand the dynamics of the behavior of the virus and dissemination of the new agent. Objectives: A retrospective descriptive epidemiological study of the 26 state capitals of Brazil and its capital, Brasilia, was performed to investigate the behavior of the infection and disease caused by SARS-CoV-2. Study design: The data presented were obtained from the State Health Departments and the Brazilian Ministry of Health. Seven epidemiological markers (including the incidence, mortality and case fatality rates and the growth of the epidemic measured by the ratios observed on days 30, 60 and 90) were compared for the initial 90 days of the epidemic for each city. Results: The epidemic spread to the country within 25 days, and deaths occurred as early as nine days from initiation. The incidence and mortality rates ranged from 70 to almost 1,599/100,000 and less than 1 to 1,171/1,000,000, respectively, at the end of the 90-day period of observation. The CFR was less than two up to 12.31%. The magnitude of each marker clustered the cities in different groups. The epidemic was managed differently in each city, with differences in qualified medical services and medical preparedness to face the emergency situation. Conclusions: Although modeling the epidemic has been a constant task, epidemiological data should be pursued to define actual information, such as the prevalence and incidence rates, to understand the unpredictable nature of this emerging infection, including the present policy of vaccination campaigns.

Indexed as

BrazilCovid-19EpidemiologyHuman coronavirusSars-cov-2Transmission

Identifiers

PMID35262029
PMCPMC8574077

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.